Slideshow

Endo News Roundup: Diabetic Retinopathy

Author(s):

April news highlights the importance of timely eye examinations in young patients with diabetes and the efficacy of a teleretinal screening program.

New studies in diabetes highlight the use of real-time continuous glucose monitoring in type 1 diabetes mellitus (DM) to reduce hemoglobin A1c (HbA1c), primarily in those over age 15 years; how a teleretinal diabetic retinopathy screening program can reduce wait times for screening and improve timeliness of needed care; and note that many young diabetes patients who have health insurance do not receive timely eye examinations to monitor for diabetic retinopathy.

Related Videos
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
© 2024 MJH Life Sciences

All rights reserved.